1Scott WJ,Howington J,Feigenberg S,et al.Treatment of nonsmall cell lung cancer stage Ⅰ and stage Ⅱ:ACCP evidence-based clinical practice guidelines(2nd edition).Chest,2007,132(3 Suppl):234-242.
2Raz DJ,Zell JA,Ignatius OS,et al.Natural history of stage Ⅰ non-small cell lung cancer:implications for early detection.Chest,2007,132:193-199.
3Patrick T,Susan GA,Elizabeth A.New guidelines to evaluate the response to treatment in solid tumors.J Natl Cancer Inst,2000,92:205-215.
4National Cancer Institute.Cancer therapy evaluation program,common terminology criteria for adverse events.version 3.0.Washington:NCI,2003.
5Ginberg RJ,Rubinstein LV.Lung Cancer Study Group(1995)Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer.Ann Thorac Surg,1995,60:615-623.
6Mountain CF.A new international staging system for lung cancer.Chest,1986,89:225-233.
7Timmerman R,Papiez L,McGarry R,et al.Extracranial stereotacti cradioablation:results of a phase Ⅰ study in medically inoperable stage Ⅰ non-small cell lung cancer.Chest,2003;124:1946-1955.
8Krol AD,Aussems P,Noordijk EM,et al.Local irradiation alone for peripheral stage Ⅰ lung cancer:could we omit the elective regional nodal irradiation? Int J Radiat Oncol Biol Phys,1996,34:297-302.
9Williams TE,Thomas CR,Jr,Turrisi AT,Ⅲ.Counterpoint:better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation.Semin Radiat Oncol,2000,10:308-314.
10Baumann P,Nyman J,Lax I,et al.Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage Ⅰ lung cancer.A retrospective analysis of patients treated in the Nordic countries.Acta Oncol,2006,45:787-795.
